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Abstract
Biofilms are structured aggregates of bacterial cells that are embedded in self-
produced extracellular polymeric substances. Various pathogens initiate a disease 
process by creating organized biofilms that enhance their ability to adhere, replicate 
to accumulate, and express their virulence potential. Quorum sensing, which 
refers to the bacterial cell-to-cell communication resulting from production and 
response to N-acyl homoserine lactone signal molecules, also plays an important 
role in virulence and biofilm formation. Attenuation of microorganisms’ virulence 
such that they fail to adapt to the hosts’ environment could be a new strategic fight 
against pathogens. Thus, agents or products that possess anti-biofilm formation 
and/or anti-quorum sensing activities could go a long way to manage microbial 
infections. The incidence of microbial resistance can be reduced by the use of anti-
biofilm formation and anti-quorum sensing agents.
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1. Introduction
Biofilm is a population of cells growing on a surface and enclosed in an exopoly-
saccharide matrix [1]. The physiology, structure and chemistry of the biofilm vary 
with the nature of its resident microbes and local environment [2].
Most important feature among biofilms is that their structural integrity critically 
depends upon the extracellular matrix produced by their constituent cells. They are 
notoriously difficult to eradicate and are a source of many recalcitrant infections 
[2]. Biofilms are associated with serious health issues stemming from persistent 
infections due to the contamination of medical devices (intravenous and urinary 
catheters), artificial implants and drinking water pollution among others [3].
Intercellular signaling, often referred to as quorum sensing (QS), has been 
shown to be involved in biofilm development [4]. Quorum sensing relies on small, 
secreted signaling molecules; much like hormones in higher organisms, to initi-
ate coordinated responses across a population and it contributes to behaviors that 
enable microbes to resist antimicrobial compounds [5]. Quorum sensing signaling 
activation can lead to antimicrobial resistance of the pathogens, thus increasing the 
therapy difficulty of diseases [4].
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The key concern about biofilms is their contribution to the development of 
resistance against antimicrobial agents, and with the on-going emergence of 
antibiotic-resistant pathogens, there is a current need for development of alterna-
tive therapeutic strategies [6].
An anti-virulence approach by which quorum sensing is impeded could be a 
viable means to manipulate bacterial processes, especially pathogenic traits that 
are harmful to human and animal health and agricultural productivity [7]. Further 
research into the identification and development of chemical compounds and 
enzymes that facilitate quorum-sensing inhibition (QSI) by targeting signaling 
molecules, signal biogenesis, or signal detection are required [7]. Anti-QS agents 
can abolish the QS signaling and prevent the biofilm formation, therefore reducing 
bacterial virulence without causing drug-resistant to the pathogens, suggesting 
that anti-QS agents could be potential alternatives for antibiotics [8]. An effective 
clinical strategy for treating bacterial diseases in the near future will be to combine 
anti-QS agents with conventional antibiotics since this can significantly improve the 
efficacy of therapeutic drugs and decrease the cost of human healthcare [9].
2. Microbial biodiversity in biofilm systems
Biofilms are mixed microbial cultures normally consisting predominantly of 
prokaryotes with some eukaryotes. Thus, in addition to microbial cells, the sur-
rounding environment contains a range of macromolecular products in which exo-
polysaccharide secreted by the cells is the dominant macromolecular component, 
while the water content is probably about 90–97% [10, 11]. Secreted products also 
include enzymes and other proteins, bacteriocins, and low mass solutes and nucleic 
acid released through cell lysis. The lysis may occur either naturally with cell aging 
or through the action of phage and bacteriocins.
Opportunistic pathogens, viruses, parasitic protozoa, toxin releasing algae and 
fungi and enteric bacteria e.g. Escherichia coli, Klebsiella pneumoniae, Klebsiella oxy-
toca, Enterobacter cloacae, Enterobacter agglomerans, Helicobacter pylori, Shigella spp., 
Campylobacter spp., Salmonella spp., Clostridium perfringens, Enterococcus faecium, 
Enterococcus faecalis and environmental pathogenic bacteria like Legionella pneu-
mophila, Pseudomonas aeruginosa, Pseudomonas fluorescens, Aeromonas hydrophila, 
Aeromonas caviae, Mycobacterium avium, Mycobacterium xenopi etc. are associated 
with biofilms present in drinking water [12, 13].
Biofilms present complex assemblies of microorganisms attached to surfaces. 
They are dynamic structures in which various metabolic activities and interactions 
between the component cells occur [10]. Studies on microorganisms and biofilm 
formation have revealed diverse complex social behavior including cooperation in 
foraging, building, reproduction, dispersion and communication among microor-
ganisms [14]. The organisms within a biofilm setup may include a single or diverse 
species of microorganisms. In the biofilm, bacteria can share nutrients and are 
sheltered from harmful factors in the environment, such as desiccation, antibiotics, 
and a host body’s immune system.
Bacteria, fungi, viruses, protozoa and cyanobacteria that are common pathogens 
are all involved in biofilm formation [15].
2.1 Bacterial biofilms
About 99.9% of all bacteria live in biofilm communities [16]. A biofilm usually 
begins to form when a free-swimming bacterium attaches to a surface. Pathogenic 
organisms are found on most food items including seafoods and biofilm forming 
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pathogens are found on such seafoods as crabs [17], pacific oysters [18], shrimps 
[19] etc. Public health and clinical microbiologists recognize that biofilms are 
present everywhere in nature and are responsible for a number of human infec-
tions. Infectious caused by microbial communities include urinary tract infections, 
middle-ear infections, dental plaque, gingivitis, endocarditis, cystic fibrosis. 
Biofilms on persistent indwelling devices such as catheter, contact lenses, heart 
valves and joint prostheses are also responsible for many recurrent infections [20, 
21]. Biofilms on indwelling medical devices may be composed of Gram-positive or 
Gram-negative bacteria. Bacteria commonly isolated from these devices include 
the Gram-positive Enterococcus faecalis, Staphylococcus aureus, Staphylococcus epider-
midis, and Streptococcus viridans; and the Gram-negative Escherichia coli, Klebsiella 
pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa [22]. It has been shown 
that virtually all indwelling central venous catheters are colonized by microorgan-
isms embedded in a biofilm matrix. Among these S. epidermidis and S. aureus are 
commonly present on cardiovascular devices [23], causing about 40–50% of infec-
tions related to heart valve [14].
The organisms that form biofilms on medical devices originate from patient’s 
skin microflora, exogenous microflora from health-care personnel, or contaminated 
infusates. Biofilms associated with catheters may initially be composed of single 
species, but with the passage of time they become multi-specie communities. Some 
urinary tract and bloodstream infections are also caused by biofilm-associated 
indwelling medical devices with 50–70% of infections related to catheter [12]. 
Chronic infections, inflammation and tissue damage caused by many strains of 
single species are often found in polymicrobial communities [24].
Bacteria that reside in a biofilm community usually will not grow when cultured, 
a situation normally referred to as “viable, but not culturable”. The reason is that to 
change to the planktonic state from a biofilm-producing phenotype, bacteria require 
complex and specific environmental and signaling factors that are not available in a 
culture plate [25]. This therefore suggests that analyzing biofilm samples for bacte-
rial infective agents during infections may show negative results and the real cause of 
the infections may not be detected if culturing is the only investigative procedure.
2.2 Fungal biofilms
Many medically important fungi produce biofilms and they include Candida, 
Aspergillus, Cryptococcus, Trichosporon, Coccidioides, and Pneumocystis. Candida albi-
cans biofilms are primarily made up of yeast-form and hyphal cells, both of which 
are required for biofilm formation [26]. The formation of Candida albicans biofilm 
follows a sequential process that involves adherence to a substrate (either abiotic 
or mucosal surface), proliferation of yeast cells over the surface, and induction of 
hyphal formation [27]. As the biofilm matures extracellular matrix (ECM) accumu-
lates. Many other Candida spp. form ECM-containing biofilms but do not produce 
true hyphae and they include Candida tropicalis, Candida parapsilosis, and Candida 
glabrata [28]. Aspergillus biofilms can form both on abiotic and biotic surfaces and 
the initial colonizing cells that adhere to the substrate are conidia. Mycelia (the 
hyphal form) develop as the biofilm matures [29]. Aspergillus fumigatus produces 
two forms of biofilm infections: Aspergilloma and Aspergillosis. Aspergilloma 
infections present an intertwined ball of hyphae while aspergillosis infections pres-
ent individual separated hyphae [30].
Trichosporon asahii forms biofilms comprised of yeast and hyphal cells embed-
ded in matrix, as do those of Coccidioides immitis. Cryptococcus neoformans forms 
biofilms consisting of yeast cells on many abiotic substrates [31]. Although 
Cryptococcus neoformans forms hyphae in the course of mating, no hyphae have 
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been observed in Cryptococcus neoformans biofilms. Similarly, Pneumocystis species 
do not produce hyphal structures as part of their biofilms [32]. Hyphal formation is 
therefore, not a uniform feature of fungal biofilms.
2.3 Protozoan biofilms
Free-living protozoans are single celled eukaryotic organisms and are divided into 
amoebae, flagellates and ciliates. All the three protozoan groups have been found in fresh 
water biofilms. Although many different species are found in association with biofilms, 
their level of association differs. The protozoans Cyclospora cayetanensis, Cryptosporidium 
spp., and Toxoplasma gondii have all been found in biofilm communities [22].
2.4 Virus involvement in biofilms
Viruses are obligatory intracellular parasites and are found in communities 
where cells in which they live are found. Viruses are, thus, found in biofilms com-
munities associated with the bacteria, fungi and protozoa they infect.
Many phages may produce polysaccharases or polysaccharide lyases. Some phages 
are also known to produce enzymes that degrade the poly-Q-glutamic acid capsule of 
Bacillus spp. [33]. Various structures including extracellular polymers and heterolo-
gous microbial cells may impede viral access to the bacterial cell surface. Phage may 
carry on their surfaces enzymes that degrade bacterial polysaccharides including 
those of biofilm structures. These enzymes are very specific and seldom act on more 
than a few closely related polysaccharide structures [34]. Numerous phages have 
been isolated which induce enzymes capable of degrading the exopolysaccharide of 
various Gram-negative bacterial genera. These include phage for biofilm-forming 
bacteria. It has been observed that the extracellular matrix of the biofilms does not 
protect the bacterial cells from infection with phage T4 [35].
Many biofilms possess an open architecture with water-filled channels, which 
would allow the phage access to the biofilm interior [36]. As biofilms age and cells 
die and slough off, potential new viral receptor sites may become available. As 
bacteria excel at adapting to differing nutrient conditions, changes to the host cell 
surface could be expected with either loss or gain of possible phage receptors. A 
further factor which might influence phage retention within biofilms lies in the role 
of hydrophobic and electrostatic interactions. In the interaction of a coliphage with 
both hydrophobic and hydrophilic membranes, a critical factor in the retention of 
the phage was its iso-electric point [37].
In complex biofilms in natural environments, eukaryotic algae may also be 
present [38]. Under these circumstances algal cell lysis through viral action is also 
possible as many viruses for algal species have now been isolated and identified [39].
3. Biofilms in respiratory tract infections
It is becoming progressively more accepted that biofilm formation is an impor-
tant cause of morbidity in respiratory tract infections [40]. Biofilms may be involved 
in some respiratory infections, including ventilator-associated pneumonia, bronchi-
ectasis, bronchitis, cystic fibrosis and upper respiratory airway infections [41].
3.1 Upper respiratory tract infections
Infectious diseases that affect the upper respiratory tract include otitis media, 
sinusitis, tonsillitis, adenoiditis, pharyngotonsillitis, adenoiditis and chronic 
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rhinosinusitis [42]. In otitis media, infections may be as a result of both respiratory 
viruses and bacteria such as non-capsulated Haemophilus influenza, Streptococcus 
pneumonia, Streptococcus pyogenes, Moraxella catarrhalis and Staphylococcus aureus, 
triggering the appearance of polymicrobial biofilms [43].
The most cited reason for childhood visits to physicians is otitis media with 
effusion (OME) and is again one of the most reasons for antibiotic therapy in 
children. Even though OME is regarded as a sterile inflammatory process, current 
data using a chinchilla model suggest that viable bacteria are present in intricate 
communities referred to as mucosal biofilms [44]. It is interesting to know that 
intracellular Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus 
and Moraxella catarrhalis in situ are found in adenoids from children going through 
adenoidectomy for the treatment of hypertrophic adenoids or chronic otitis media 
using Fluorescence in situ hybridization [45]. Haemophilus influenzae and intracel-
lular S. pneumoniae have also been in middle ear mucosal biopsies in children with 
chronic otitis media [46].
Biofilms were seen in the sinus tissues of 72% of patients affected by chronic 
rhinosinusitis and the cultured organisms identified included H. influenzae 
(28%), P. aeruginosa (22%), S. aureus (50%), and fungi (22%). The presence of 
bacterial biofilms was linked to persistent mucosal inflammation after endoscopic 
sinus surgery [47]. Assessment of some chronic infections in the upper respira-
tory tract including recurrent tonsillitis and chronic rhinosinusitis in human 
clinical specimens suggests that both attachment and aggregated bacteria are 
present [48]. For instance, electron microscopy and culture were used to show 
that biofilms were associated with the mucosal epithelium of tonsils in 73% of 
tonsils removed for tonsillitis and 75% of those tonsils removed due to hypertro-
phic tonsils alone [49]. Calo et al. [42] found bacterial biofilms in recurrent and 
chronic infectious diseases of the upper respiratory tract (adenoiditis, tonsillitis, 
and chronic rhinosinusitis) and concluded that biofilms formation plays a role in 
upper airway infections.
3.2 Tissue-related infections
3.2.1 Cystic fibrosis (CF)
Cystic fibrosis (CF) is a protracted disease of the lower respiratory tract. 
The most frequent serious clinical complication in CF today is chronic endo-
bronchial infection with Pseudomonas aeruginosa. Pseudomonas aeruginosa is 
a microorganism characterized by the capacity to produce large amounts of 
alginate and developed as a biofilm where micro-colonies of bacteria embedded 
in a matrix of alginate attack the lower respiratory tract [42]. Cystic fibrosis 
occurs as a result of a mutation in the CF transmembrane conductance regulator 
gene that encodes a cyclic AMP-regulated chloride ion channel. The mutation 
causes defective ion transport across epithelial cell surfaces in the upper air-
ways, interfering with the removal of particles and microbial cells trapped in 
the overlying mucus and causing increased susceptibility to bacterial infection. 
Therefore, the airways of patients with CF are almost always infected with dif-
ferent bacterial species, but P. aeruginosa infection causes the greatest problem 
of morbidity and mortality [43]. Pseudomonas aeruginosa is the most common 
bacterial species that causes respiratory tract infection in CF patients and can be 
seen in about half of all cases and in up to 70% of adults [44]. Other pathogens 
such as Staphylococcus aureus, Achromobacter xylosoxidans, Burkholderia cepacia 
complex and Stenotrophomonas maltophilia have also been found to cause CF and 
are linked to biofilm formation [45].
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3.2.2 Cystic fibrosis with chronic lung infections
A major difficulty in this type of infection is contamination of lower respira-
tory secretions with the normal oropharyngeal flora, particularly as members of 
the normal flora (e.g. Haemophilus influenzae, Staphylococcus aureus, Streptococcus 
pneumonia and Moraxella catarrhalis) are common lung pathogens in CF [46, 47]. 
The incidence of bacterial lung infections in CF is high because the mucoid polysac-
charidic material that accumulates on the respiratory epithelium due to the fact that 
impaired mucociliary removal in the bronchi of such patients favors biofilm forma-
tion. The capacity of Pseudomonas aeruginosa to form biofilms is believed to be the 
primary reason for its survival in the CF lung, despite a high inflammatory response 
and intensive antibiotic treatment [48]. Chronic airway infections cause an increase 
deterioration of lung tissue, a decline in pulmonary function and, finally, respira-
tory failure and death in cystic fibrosis (CF) patients [49].
3.2.3 Chronic obstructive pulmonary disease (COPD)
The role of biofilms in patients with COPD has not been directly validated but 
has been hypothesized considering the evidence showing that the respiratory tracts 
of these patients are frequently colonized by pathogens. Murphy and Kirkham [50] 
have recently confirmed that biofilms do play a role in COPD where they identified 
major outer membrane proteins of Non-typeable H. influenzae during its growth as 
a biofilm. Even if direct proof of biofilm formation in vivo is lacking, biofilms may 
reasonably be considered to be involved in the vicious cycle of infection/inflamma-
tion leading to disease development in patients with COPD [51].
3.2.4 Non-cystic fibrosis bronchiectasis
In bronchiectasis not due to cystic fibrosis, infections result in changes in the 
muscular and elastic components of the bronchial wall, which become distorted and 
expanded. Airways gradually become unable to clear mucus, leading to serious lung 
infections, which in turn cause more damage to the bronchi [52]. Recently biofilm 
formation has been demonstrated in vivo and is assumed to play a significant role in 
the pathophysiological cascade of the disease [53]. Bacterial biofilm formation by 
Pseudomonas aeruginosa or Klebsiella pneumoniae is common in bronchiectasis and 
could be an essential factor that makes infections in bronchiectasis obstinate. Other 
pathogens such as Prevotella sp., Veillonella sp. and Neisseria sp. have also been identi-
fied recently in patients with bronchiectasis to form biofilms [54].
3.2.5 Bronchitis
Prolonged bacterial bronchitis may be caused by chronic infections of the 
respiratory tract. In children especially, the condition appears to be secondary to 
impaired mucociliary removal that produces an environment favorable for bac-
teria to become established, usually in the form of biofilms. The most commonly 
involved bacteria include Haemophilus influenzae (30–70%), Moraxella catarrhalis 
and Streptococcus pneumonia [55].
3.2.6 Diffuse pan-bronchiolitis
Diffuse pan-bronchiolitis (DPB) is an unusual inflammatory lung disease of 
unknown etiology found in adult Japanese patients. With this disease, chronic 
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endobronchial infection with Pseudomonas aeruginosa biofilms leading to 
respiratory failure is common. It is a severe, progressive form of bronchiolitis 
(Inflammation and congestion in the bronchioles of the lung) [56].
3.3 Device-related infections
In device-related infections such as ventilator-associated pneumonia (VAP), 
biofilms result in microbial persistence and reduced response to treatment. 
Biofilm formation within the first 24 h after intubation has been reported in 
95% of endotracheal tubes [57]. Pathogens in both endotracheal tube bio-
film and secretions accrued within the airways/endotracheal tubes in 56 to 
70% of patients with VAP have been reported. Pseudomonas aeruginosa and 
Acinetobacter baumannii are the most common bacteria that colonize these 
devices [57].
3.4 Biofilm forming organisms associated with respiratory tract infections
This section presents the role of biofilms in respiratory tract infections, with 
specific emphasis on the biofilms formed by Pseudomonas, Staphylococcus, and 
Haemophilus, the primary pathogens associated with respiratory tract infections 
[58] although additional important pathogens, including Streptococcus pneumoniae, 
Bordetella and Mycobacterium species do play a role [59].
3.4.1 Biofilms formed by Pseudomonas aeruginosa
Pseudomonas aeruginosa is a recognized common pathogen in respiratory tract 
infections although other members of the genus Pseudomonas are able to form 
biofilms [7]. Respiratory infections caused by P. aeruginosa are a major globally 
clinical issue, especially for patients with chronic pulmonary disorders, such as 
those with cystic fibrosis (CF), non-CF bronchiectasis, severe chronic obstruc-
tive pulmonary disease (COPD) and ventilator-associated pneumonia [60]. This 
bacterium is a difficult opportunistic pathogen that readily forms biofilms on 
most surfaces [5]. The intricate steps of biofilm formation by P. aeruginosa are 
considered to be a developmental process. The stages of P. aeruginosa biofilm 
formation can be seen by several strategies. One easy technique is the scanning 
electron microscope (SEM) of P. aeruginosa grown on glass surfaces or tracheal 
explants. Biofilms form when planktonic P. aeruginosa bacteria get attached to a 
surface using adhesins such as type IV fimbriae and flagella, and begin to colo-
nize. In this regard type IV fimbriae and flagella P. aeruginosa mutants are severely 
compromised in initiation of biofilm formation [58, 61]. Additionally, the process 
of surface translocation mediated by type IV fimbriae (twitching motility) is 
essential for initiation of biofilm formation by P. aeruginosa [58]. Most probable, 
twitching motility confers synchronized cell movement along the surface as well 
as cell–cell communications that lead to the formation of micro-colonies. The 
coordination of events for the initiation and formation of biofilms requires cell–
cell interactions that are mediated by quorum sensing [62]. Following this, the 
micro-colonies mature into distinctive three-dimensional structures that pose the 
most severe scenario for clinical treatment. This structure is typically trapped in a 
matrix material that may be composed of protein, polysaccharide, or nucleic acid. 
Nonetheless, it has been proposed guluronic and mannuronic acids [63] are the 
major constituents of the biofilm matrix [64]. Recent data also suggest that DNA 
also contributes to this matrix [60].
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3.4.2 Biofilms formed by Staphylococcus species
The adherence of Staphylococcus directly to an implanted device (intravascular 
catheters, prosthetic devices, and other indwelling medical devices) or indirectly 
via host proteins is the first step in the development of a biofilm. This is followed 
by a buildup of multilayered cell clusters on the polymer surface [65]. When 
Staphylococcus bacteria get within 50 nm of a surface, they adhere through hydro-
phobic interactions, van der Waal’s forces, and when present, fimbriae and pili 
also contribute to its adhesion [66]. A biofilm-associated protein (Bap) is reported 
to contribute to S. aureus biofilm formation. The second phase of Staphylococcus 
biofilm formation is the accumulation of complex cell clusters mediated by inter-
cellular adhesion. A 140 kDa extracellular protein, known as the accumulation 
associated protein (AAP), appears responsible for accumulative growth on polymer 
substances [67]. It has been hypothesized that AAP is involved in anchoring the 
polysaccharide adhesion PIA (polysaccharide intercellular adhesion) to the cell sur-
face [63]. The extracellular polysaccharide adhesion antigen PIA is a well-described 
polysaccharide antigen that is linked to cellular aggregation or clustering. Lastly, 
the generation of a slime glycocalyx is believed to be the climaxing event in the 
staphylococcal biofilm developmental process. This slime layer is not essential for 
surface colonization and appears variable between strains. However, when present, 
the slime layer protects the bacteria from host defenses and some antibiotics. As in 
P. aeruginosa, organization of complex communities within Staphylococcus biofilms 
is a coordinated effort and requires cell–cell communication [68].
3.4.3 Biofilms formed by Haemophilus influenzae
Non-typeable H. influenzae (NTHI) strains are members of the normal human 
nasopharyngeal flora, as well as frequent opportunistic pathogens of both the upper 
and lower respiratory tracts. It is an important cause of otitis media in children 
and lower respiratory tract infection in adults with chronic obstructive pulmonary 
disease (COPD). Recently, it has been shown that NTHI can form biofilms both in 
vitro and in vivo [69]. Considerable diversity in the ability of NTHi isolates to form 
biofilms has also been reported. A NTHi pilus defective strain was reduced three-to 
four fold in biofilm formation compared with its isogenic parental NTHi isolate, 
signifying a role of the pilus in biofilm development. Although this is the case for 
other gram-negative bacteria [70], nonetheless, it is quite clear that NTHi strains 
have the ability to form biofilms both in vitro and in vivo [69]. Earlier studies of 
cell envelopes during growth of H. influenzae as a biofilm established an increased 
abundance of a ~30 kDa protein [58], peroxiredoxin-glutaredoxin (PGdx) [71], that 
is expressed by H. influenzae during biofilm growth and this probably contributes to 
its persistence in the upper respiratory tract infections.
3.4.4 Biofilms formed by other microorganisms
Streptococcus pneumoniae: Streptococcus pneumoniae is a frequent colonizer of 
the human nasopharynx and a significant human respiratory pathogen that causes 
a variety of diseases such as community-acquired pneumonia and otitis media in 
children [72]. Colonizing pneumococci form well-ordered biofilm communities in 
the nasopharyngeal environment, but the exact role of biofilms and their interac-
tion with the host during colonization and disease is not yet explicit [73]. However, 
investigators have speculated that pneumococci form biofilms in the nasopharynx 
in vivo [74]. Recently, pneumococci have been reported for the first time to form 
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highly structured biofilms during colonization of the murine nasopharynx [75]. 
Mice were also inoculated intranasally with the pneumococcal strain EF3030, 
a clinical isolate known to be non-invasive and an efficient colonizer in murine 
models, and found to form biofilms [76].
Bordetella species: Bordetellae are respiratory pathogens that infect both humans 
and animals. Bordetella bronchiseptica causes asymptomatic and long-term to life-
long infections in animal nasopharynges while the human pathogen, B. pertussis is 
the etiological agent of the acute disease whooping cough in infants and young chil-
dren. One proposed hypothesis to explain the survival and continued persistence 
of Bordetella spp. in the mammalian nasopharynx is that these organisms produce 
surface-adherent communities known as biofilms [77]. Researchers have recently 
established the ability of the three classical Bordetella species (Bordetella pertussis, 
Bordetella bronchiseptica, and Bordetella parapertussis) to form biofilms on abiotic 
surfaces [78]. It is assumed that Bordetella biofilm formation may play a role in the 
pathogenic cycle, precisely in persistence within the nasopharynx [79]. The capac-
ity to form biofilms in mice suggests a role for Bordetella mode of existence during 
human infections. Clusters and tangles (reminiscent of biofilms) of Bordetella 
pertussis adherent to ciliated cells in explant cultures and tissue biopsies of pertus-
sis patients have been documented [79]. As reported for other biofilm-forming 
organisms, extracellular DNA and exopolysaccharide are vital for biofilm formation 
by Bordetella bronchiseptica. The observation of biofilm-like structures in vivo in 
the nasal epithelium of Bordetella bronchiseptica infected mice showed that these 
communities expressed a polysaccharide essential for in vivo biofilm development 
[75, 76]. In Bordetella, BvgAS-regulated factors, including the filamentous hemag-
glutinin and adenylate cyclase, may also contribute to biofilm formation [79].
Mycobacterium species: Mycobacterial infections have been shown to form 
biofilms, most notably Mycobacterium tuberculosis, which under the conducive 
environments, can self-assemble. Among the non-tuberculous mycobacteria, 
Mycobacterium avium complex (MAC) and the rapidly growing mycobacteria, 
including Mycobacterium abscessus complex, have been reported to produce biofilms 
either in vitro or in environmental reservoirs [80], but in vivo conditions have not 
been investigated. Mycobacterium abscessus complex is an evolving threat to patients 
with cystic fibrosis [81], that become infected at an early stage and worsens clini-
cally as the persistent infection results in inflammation and tissue damage.
4. Quorum sensing
In the control of microbial infections, two strategies are normally envisaged; 
killing the organisms or attenuation of the organisms’ virulence such that they 
fail to adapt to the host environment. The former approach is what is generally 
favored; the latter lacks specific targets for rational drug design. It has, however, 
been realized that Gram-negative bacteria use small molecules known as acyl 
homoserine lactones to regulate the production of secondary metabolites and 
virulence factors, and this could offer a novel target to address the strategy of 
attenuating the organisms’ virulence thereby impairing their adaptation to the host 
system. Recent research has highlighted the importance of cell-to-cell interactions 
or communications, referred to as Quorum Sensing (QS), in microorganisms. Many 
bacterial species employ a complex mechanistic communication system to transmit 
information among themselves. Bacteria can act in response to a variety of chemical 
signals produced by the same species along with others produced by other species, 
and this provides a way for intraspecies and interspecies cross-communication 
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and interruption of signals. The ability of bacteria to dispatch, pull together, and 
process information allow them to act as “multicellular” organisms and enhance 
their survival in complex environments [82].
Any mechanism capable of disrupting QS signals can be used to reduce survival 
of the microorganism thereby preventing or reducing virulence in the host environ-
ment. Such methods of interruption of the QS include:
• Disruption of biosynthesis of signal molecules,
• Application of QS antagonists (e.g. use of extracts from higher plants and algae 
and other chemical compounds),
• Chemical inactivation of quorum sensing signals,
• Biodegradation of signal molecule.
Agents capable of inhibiting the growth of microorganisms or disrupting the 
quorum sensing mechanisms of the microorganisms or interrupting the biofilm 
formation may be useful in the fight against microbial pathogenicity.
4.1 Anti-quorum sensing activity
It has now become apparent that different types of microorganisms have evolved 
the ability to recognize and act in response to the presence of other microorganisms 
in their neighborhood. Most Gram-negative bacteria produce and respond to N-acyl 
homoserine lactone (AHLs) signal molecules to regulate production of secondary 
metabolites in order to monitor their own population density. These molecules, at 
a threshold population density, act together with cellular receptors and elicit the 
expression of target genes such as those involved in virulence, antimicrobial pro-
duction, motility and swarming, sporulation, bioluminescence and biofilm forma-
tion. The concept of quorum sensing (QS) was initially described in Vibrio fischeri, 
a luminescent marine bacterium. It was observed that the organisms express genes 
controlling light emission (the luciferase enzyme) when in symbiotic association 
with its hosts, the squid [83]. At low population densities (i.e. free-living in seawa-
ter) Vibrio fischeri does not express luciferase and so is non-luminescent. However, 
when cultured in the laboratory to high cell densities, they express bioluminescence 
with a blue-green light. They do not emit light unless they detect a concentration 
high enough of their own AHL. These organisms usually form symbiotic relation-
ships with some fish and squid species such as Euprymna scolopes. Euprymna scolopes 
appears bioluminescent in dark surroundings because of high-population of the 
cells (Vibrio fischeri) in a specialized light organ. Euprymna scolopes, in return, offers 
nutrients to the Vibrio fischeri population. The QS system originally identified in 
Vibrios involved two genes, luxl and luxR. The Luxl codes for an enzyme, which 
synthesizes 3-oxo-C6-homoserine lactone (an auto-inducer as they are produced by 
the same cells whose metabolism they regulate) [82].
The unpleasant side effects of antibiotics (such as ototoxicity and nephrotoxic-
ity associated with the aminoglycosides) have led to preference for preventive 
rather than curative approach towards fighting infectious diseases. Inhibition of 
quorum sensing activity has been hypothesized as one approach that can be use-
ful in preventing bacterial infection. It could provide an additional approach to 
antibiotic mediated bactericidal or bacteriostatic activity thereby reducing the 
risk of successful establishment of infections or resistance development in the 
bacteria. This is supported by the protective effect of QS inhibition demonstrated 
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in animal infection models. A simple animal infection model on QS was launched in 
Caenorhabditis elegans, a nematode that feeds on bacteria. When fed on opportunis-
tic pathogens such as P. aeruginosa, the worm was mostly destroyed within a short 
time after taking in the bacteria; presumably annihilated by the actions of cyanide 
and phenazines produced by the bacteria [84]. However, in instances where the 
worms ingested P. aeruginosa with mutations in the QS-controlling systems, they 
were not killed but were rather sustained on the bacteria. This model highlights the 
involvement of QS-regulated virulence factors in pathogenicity of Pseudomonas 
aeruginosa. It is obvious from such models that interruption of the QS apparatus 
of bacteria by plant extracts or other chemical compounds may offer a novel and 
an exciting approach to fight the existing problems associated with antimicrobial 
chemotherapy.
Many bacteria produce AHL molecules in response to QS and so could be used 
as biomonitor organisms in screening of compounds for anti-QS activity. Such 
bacteria include Chromobacterium violaceum, Erwinia carotovora and Pseudomonas 
aeruginosa.
5. Medicinal plants with biofilm inhibition activity
Natural products have been identified to inhibit biofilm formation in micro-
organisms. The exact mechanism for most of the agents is yet to be elucidated. 
Medicinal plants have been identified as rich source of bioactive compounds that 
have the capability of interfering with biofilm formation but most of these studies 
are still in the early stages of drug development. The anti-biofilm effects of medici-
nal plants have been proposed to be due to the inhibition of formation of polymer 
matrix, suppression of cell adhesion and attachment, interruption of extracellular 
matrix formation and reduction in virulence factors production and activation, 
thereby blocking QS network and biofilm development [85].
Medicinal plants belonging to various plant families reported to have biofilm 
inhibitory activity are listed in Table 1; the part of the plant (leaves, fruits, stem 
Plant name Family Part used Solvent Biofilm 
inhibition 
activity
Reference
Punica granatum 
L
Lythraceae Fruit Methanol Inhibit biofilm 
formation in E. 
coli by 70% at 
150 μg/mL
[86]
Salvia fruticosa 
Mill.
Lamiaceae Aerial 
parts
Ethanol Inhibit biofilm 
formation 
by 60.9% at 
0.78 mg/mL
[87]
Vaccinium 
corymbosum L
Ericaceae Fruit Decoction Reducing 47% 
MRSA biofilm 
viable counts. 
12.5 mg/mL
[88]
Commelina 
benghalensis L.
Commelinaceae Whole 
plant
Distilled 
water
Inhibited 
the biofilm 
formation at 
250 μg/mL
[89]
Curcuma longa L. Zingiberaceae Rhizome Aqueous Removed 30 to 
40% of biofilm 
at 5–0.63 μg/mL
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bark, rhizome) used, the various solvents used for extraction and their ability to 
inhibit cell adhesion or to eradicate biofilm formed by different pathogens have 
been mentioned.
6. Conclusion
Combatting biofilm and quorum sensing is a good strategy to reduce microbial 
pathogenicity and thus fight infections. This can be achieved by finding effective 
agents that can inhibit biofilm formation and disrupt quorum sensing mechanisms. 
Natural products particularly medicinal plants are a rich source of bioactive com-
pounds that have served as useful leads in the development of drugs. Rigorous 
evaluation of medicinal plants can therefore lead to novel anti-biofilm and anti-
quorum sensing agents.
Plant name Family Part used Solvent Biofilm 
inhibition 
activity
Reference
Euphorbia hirta 
L.
Euphorbiaceae Aerial 
parts
Methanol Biofilm 
inhibition and 
eradication 
activity against 
P. aeruginosa 
observed at 0.25 
and 0.5 mg/ml, 
respectively
[90]
Terminalia 
bellirica 
(Gaertn.) Roxb
Combretaceae Dried 
fruit
Ethanol Inhibition 
biofilm 
formation by 
89.8 and 92.2% 
at 125 and 
250 μg/mL, 
respectively
[91]
Azadirachta 
indica A. Juss
Meliaceae Leaf Distilled 
water
Reduced biofilm 
completely by 
35% at 5% w/v
[92]
Commiphora 
leptophloeos 
(Mart.) J.B. Gillet
Burseraceae Stem bark Distilled 
water
Inhibition of 
cell adhesion 
above 80% at 
4.0 mg/mL
[93]
Bauhinia 
acuruana 
(Moric)
Fabaceae Fruit Distilled 
water
Inhibition 
of biofilm 
formation was 
determined to 
be 77.8 ± 5.0% 
at 4.0 mg/mL
Camellia sinensis 
(L.) Kuntze
Theaceae Leaves Ethanol Inhibited the 
cell adhesion by 
78.7% 0.5%w/v
[94]
Table 1. 
Medicinal plants with anti-biofilm activity.
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